Erivedge approved for skin cancer metastatic basal cell carcinoma

FDA approves new treatment for most common type of skin cancer – Erivedge or vismodegib was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The Erivedge drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body (metastatic).

Gestational diabetes and poverty increased ADHD risk in offspring

Gestational diabetes and low socioeconomic status raise risk of ADHD in children – Low socioeconomic status (SES) and maternal gestational diabetes together may cause a 14-fold increased risk of attention deficit hyperactivity disorder (ADHD) in six year olds, revealed by researchers.

Malaria during pregnancy first trimester – antimalarial is safe

Malaria during pregnancy first trimester – antimalarial is safe

Malaria during pregnancy: New study assesses risks during first trimester — Antimalarial drugs safer for pregnant women than disease – The malaria disease significantly increases the risk of miscarriage, but that treating with antimalarial drugs is relatively safe and reduces this risk in pregnant women expecting their new born babies.

Polycystic ovary syndrome linked to pregnancy complications

Women with polycystic ovary syndrome at increased risk of pregnancy complications – Hormonal Disorder Linked to Pregnancy Complications – Women with polycystic ovary syndrome are more likely to have problems with pregnancy regardless of whether they are undergoing fertility treatment, claims new research published on bmj.com today.

Premature birth increases epilepsy risk later in life

Premature birth may increase risk of epilepsy later in life — Preemies are at higher risk of epilepsy later in life – Being born prematurely may increase your risk of developing epilepsy as an adult, revealed by researchers in a new study published in the Neurology, the medical journal of the American Academy of Neurology.

Healthy diet reduces birth defects risks

Overall quality of pregnant woman?s diet affects risk for two birth defects, Stanford study shows – Healthier dietary choices by pregnant women are associated with reduced risks of birth defects, including neural tube defects and orofacial clefts. Folic acid supplementation and food fortification has been effective in preventing neural tube defects, but folic acid does not prevent all birth defects.

Hormonal contraception doubles HIV risk in Africa

Study in Lancet finds use of hormonal contraception doubles HIV risk — University of Washington researchers conducted trial in Africa – Women using hormonal contraception — such as a birth control pill or a shot like Depo-Provera ? are at double the risk of acquiring HIV, and HIV-infected women who use hormonal contraception have twice the risk of transmitting the virus to their HIV-uninfected male partners.

Marriage and divorce linked to weight gain

Large weight gains most likely for men after divorce, women after marriage – Both marriage and divorce can act as “weight shocks,” leading people to add a few extra pounds-especially among those over age 30-according to new research to be presented at the 106th Annual Meeting of the American Sociological Association. But when it comes to large weight gains, the effects of marital transitions are quite different for men than they are for women.

New blood test can detect fetus gender in early pregnancy

Tests that use DNA from mother?s blood to determine sex of fetus often effective – A boy or a girl baby. Parents-to-be wishing to know the gender of their unborn baby can usually find out during a routine ultrasound performed around 20 weeks of pregnancy. Now, new technology can tell pregnant women whether they are having a boy or a girl as early as seven weeks into a pregnancy. Scientists have been making rapid progress in identifying foetal DNA in the mother’s blood to predict fetus gender.